@article{0f457225ff734bb5ae389f8803dfba12,
title = "Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome",
abstract = "To determine the frequency and consequences of neutralizing antibodies (NAbs) in patients with a first event suggestive of multiple sclerosis (MS) treated with interferon β-1b (IFNβ-1b).",
keywords = "Antibodies, Neutralizing, Cross-Sectional Studies, Demyelinating Diseases, Follow-Up Studies, Humans, Injections, Subcutaneous, Interferon-beta, Longitudinal Studies, Multiple Sclerosis, Prospective Studies",
author = "H-P Hartung and Freedman, {M S} and Polman, {C H} and G Edan and L Kappos and Miller, {D H} and X Montalb{\'a}n and F Barkhof and J Petkau and R White and V Sahajpal and V Knappertz and K Beckmann and V Lanius and R Sandbrink and C Pohl and {BENEFIT Study Group} and Frederiksen, {Jette Lautrup Battistini}",
year = "2011",
doi = "10.1212/WNL.0b013e31822c90d7",
language = "English",
volume = "77",
pages = "835--43",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams & Wilkins",
number = "9",
}